trial · primary record
DBV712 250 mcg
Peanut Allergy
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 304 |
| Primary completion | 2025-05-13 |
| Primary endpoint | Percentage of Participants Who Were Treatment Responders at Months 12, 24, 36 and 48 |
| Registry ID | NCT03859700 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:00.673Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03859700
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.